NANDU K MOHANAN

Mr. NANDU K MOHANAN


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
DMDhanya T M
Dhanya T M
Rajimon K JRajimon K J
Rajimon K J
NMNANDU K MOHANAN
NANDU K MOHANAN
AAAparna Anilkumar
Aparna Anilkumar
SPSaumya S Pillai
Saumya S Pillai
PMP V Mohanan
P V Mohanan
Benzothiophene, a sulfur-containing heterocycle, plays a crucial role in pharmaceutical and biological research due to its low toxicity, high solubility, and bioavailability. This aromatic structure, comprising a six-membered ring fused with a thiophene moiety, serves as a key scaffold for synthesizing biologically significant compounds. Benzothiophene derivatives exhibit diverse biological and pharmacological activities, including antimicrobial, anticancer, anti-inflammatory, antioxidant, antimalarial, antidiabetic, and enzyme-inhibiting properties. This study utilizes the synthesis of Schiff base ligands with the benzothiophene moiety to build coordination complexes with metals. The electron-rich sulfur and aromaticity of the benzo[b]thiophene core are well-known for their ability to stabilise the metal centres and have an impact on the coordination compounds' overall shape and reactivity. This review focuses on the advancements in the biological activities of benzothiophene compounds, emphasizing their potential as Schiff base metal complexes with enzyme-inhibiting capabilities. The discussion aims to provide new insights into the development of safer and more effective benzothiophene-based medicinal drugs, analytical agents, and pathological probes.

4 August 2025 in Inorganics
Verified
Journal Article
Open access
PDF file
NMNANDU K MOHANAN
NANDU K MOHANAN
NMNandana S Mohanan
Nandana S Mohanan
SSSurya Mol Sukumaran
Surya Mol Sukumaran
DMDhanya T M
Dhanya T M
Sneha S PillaiSneha S Pillai
Sneha S Pillai
SPSaumya S Pillai
Saumya S Pillai
Growing interest in the future applications of nanotechnology in medicine has led to groundbreaking developments in nanosensors. Nanosensors are excellent platforms that provide reliable solutions for continuous monitoring and real-time detection of clinical targets. Nanosensors have attracted great attention due to their remarkable sensitivity, portability, selectivity, and automated data acquisition. The exceptional nanoscale properties of nanomaterials used in the nanosensors boost their sensing potential even at minimal concentrations of analytes present in a clinical sample. Along with applications in diverse sectors, the beneficial aspects of nanosensors have been exploited in healthcare systems to utilize their applications in diagnosing, treating, and preventing diseases. Hence, in this review, we have presented an overview of the disease-prognostic applications of nanosensors in chronic diseases through a detailed literature analysis. We focused on the advances in various nanosensors in the field of major diseases such as cancer, cardiovascular diseases, diabetes mellitus, and neurodegenerative diseases along with other prevalent diseases. This review demonstrates various categories of nanosensors with different nanoparticle compositions and detection methods suitable for specific diagnostic applications in clinical settings. The chemical properties of different nanoparticles provide unique characteristics to each nanosensors for their specific applications. This will aid the detection of potential biomarkers or pathological conditions that correlate with the early detection of various diseases. The potential challenges and possible recommendations of the applications of nanosensors for disease diagnosis are also discussed. The consolidated information present in the review will help to better understand the disease-prognostic potentials of nanosensors, which can be utilized to explore new avenues in improved therapeutic interventions and treatment modalities.